Most rare diseases are had to treat because the economies of scale just aren't favourable. However, since they are of genetic origin, it should be possible to leverage the breakthroughs we've made in genetic engineering to find effective solutions. Since India has a number of endogamous communities, the data we can contribute could be extremely valuable.